Atlas Trials

Assess Burden of Disease Among Kidney Transplant Recipients With Chronic Active Antibody Mediated Rejection

Clinical trial NCT05452317 · COMPLETED

Trial details

NCT number
NCT05452317
Sponsor
CSL Behring
Status
COMPLETED
Study type
OBSERVATIONAL
Antibody-mediated Rejection in Kidney Transplant
Start date
2022-07-14
Primary completion
2023-04-04
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.